Hanall Biopharma Co., Ltd. (KRX:009420)
53,600
+2,800 (5.51%)
Nov 17, 2026, 3:30 PM KST
| Market Cap | 2.73T +22.8% |
| Revenue (ttm) | 162.66B +8.4% |
| Net Income | -24.90B |
| EPS | -490.57 |
| Shares Out | 50.86M |
| PE Ratio | n/a |
| Forward PE | 325.80 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 386,275 |
| Open | 50,000 |
| Previous Close | 50,800 |
| Day's Range | 50,000 - 54,200 |
| 52-Week Range | 35,100 - 73,000 |
| Beta | 0.96 |
| Analysts | Strong Buy |
| Price Target | 90,000.00 (+67.91%) |
| Est. Earnings | Feb 18, 2027 |